PSA vs PULM · rev $1.23B vs $5.4M cap
PSA (PSA) versus Pulmatrix Inc (PULM) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Pulmatrix Inc (PULM) is a biotechnology company listed on NASDAQ.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
PULM does not have a complete income-statement cache yet.
PSA currently screens at market cap $0. PULM currently screens at market cap $5.4M.
Not investment advice. Open the PSA and PULM stock pages for the full models.
Not investment advice.